Omicron News and Research

RSS

Florida Gov. Desantis falsely claims bivalent booster boosts chances of covid infection

"Almost every study now has said with these new boosters, you’re more likely to get infected with the bivalent booster."

26 Jan 2023

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Researchers discuss the efficacy of the bivalent COVID-19 vaccine against symptomatic infection with SARS-CoV-2 variants.

25 Jan 2023

FDA briefing discusses different COVID-19 vaccination regimens

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory committee meeting scheduled for January 26, 2023, the national agency proposed that people should be given yearly coronavirus disease 2019 (COVID-19) vaccines.

25 Jan 2023

Data demonstrates SARS-CoV-2 Omicron XBB.1.5 substantially escapes NAb responses after bivalent mRNA boosting

Researchers reported that the SARS-CoV-2 Omicron XBB.1.5 variant evades neutralizing response elicited by bivalent vaccine boosters.

25 Jan 2023

Maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy

Researchers assessed the impact of SARS-CoV-2 vaccination on pregnant women during the Omicron wave.

25 Jan 2023

Study points at low uptake of COVID-19 vaccine boosters by immunocompromised people in the US

Researchers performed a retrospective cohort study among immunocompromised patients registered with Kaiser Permanente Southern California (KPSC), an integrated healthcare system in the United States of America (USA) between December 14, 2020, and August 6, 2022.

25 Jan 2023

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

In a recent study posted to medRxiv*, researchers in Denmark examined the risk of adverse events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-based bivalent booster vaccination.

24 Jan 2023

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

A recent PNAS journal study has sought to address the above-stated drawback and developed a new strategy that involves a self-assembling scaffold of proliferating cell nuclear antigen (PCNA). This technique can develop nanoparticles containing evenly incorporated heterotypic antigens.

24 Jan 2023

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine

Researchers described reasons cited by adults for receiving or not receiving COVID-19 booster vaccines.

24 Jan 2023

Researchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccine

Researchers assessed the effectiveness of pan-sarbecovirus-neutralizing antibodies against SARS-CoV-2.

24 Jan 2023

Researchers report a reduction in hospitalizations and deaths from SARS-CoV-2 infections during the Omicron variant-dominated wave in Malawi

Researchers conducted a serosurvey during the SARS-CoV-2 Omicron wave in Malawi.

23 Jan 2023

In silico study suggests SARS-CoV-2 Omicron XBB.1.5 strain to be more infective than previous strains

Researchers performed an in silico analysis to estimate the relative risks of recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants.

23 Jan 2023

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Researchers examined vaccine effectiveness and pregnancy outcomes during the SARS-CoV-2 Omicron period.

23 Jan 2023

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Researchers recently assessed the clinical impact and epidemiology of viral co-detections in children in the United States of America (USA) during the coronavirus disease 2019 (COVID-19) pandemic.

23 Jan 2023

Researchers estimate COVID-19 Omicron variant mortality in Denmark

A recent Eurosurveillance study investigated how coincidental infections influenced COVID-19 mortality estimates after the emergence of the Omicron variant.

23 Jan 2023

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Researchers compared the efficiency of the SARS-CoV-2 Omicron BA.4-5 and BA.1 bivalent mRNA-booster vaccines.

23 Jan 2023

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

In a recent study posted to bioRxiv* preprint server, researchers in the United States identified several potent pan-coronavirus (CoV) inhibitors.

23 Jan 2023

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

In a recent study posted to bioRxiv* preprint server, researchers at Ohio State University examined the degree of neutralizing antibody (nAb) evasion by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB.1.5, CA.3.1, and CH.1.1 subvariants.

23 Jan 2023

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

22 Jan 2023

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

A University of Calgary research group - which includes several Bachelor of Health Sciences alumni joined forces with members of the World Health Organization to tackle a global health question.

20 Jan 2023

Omicron News and Research

Florida Gov. Desantis falsely claims bivalent booster boosts chances of covid infection

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

FDA briefing discusses different COVID-19 vaccination regimens

Data demonstrates SARS-CoV-2 Omicron XBB.1.5 substantially escapes NAb responses after bivalent mRNA boosting

Maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy

Study points at low uptake of COVID-19 vaccine boosters by immunocompromised people in the US

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine

Researchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccine

Researchers report a reduction in hospitalizations and deaths from SARS-CoV-2 infections during the Omicron variant-dominated wave in Malawi

In silico study suggests SARS-CoV-2 Omicron XBB.1.5 strain to be more infective than previous strains

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Researchers estimate COVID-19 Omicron variant mortality in Denmark

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News